In Switzerland, 32,000 people were hospitalised each year between 2012 and 2019 due to side effects of medications. This is shown for the first time in a joint study by the Universities of Lucerne and Zurich, the University Hospital Zurich and Swissmedic.
This content was published on
2 minutes
Keystone-SDA
Português
pt
Efeitos colaterais de medicamentos provocam 700 mortes por ano na Suíça
During the eight-year study period, adverse drug reactions accounted for 2.3% of all hospital admissions, according to the study. Nearly half of those admitted for side effects (46.9%) were over the age of 65.
The most common side effects noted were related to the digestive system (such as gastrointestinal inflammation), genitourinary system (for example, acute renal failure), or mental/behavioral state (such as opioid dependence).
Some 2.2% of those hospitalised due to side effects, or about 700 per year, died in hospital, the study further shows. Of these deaths, around 12% were reported to Swissmedic.
Despite the legal obligation to report, only about 5% of these hospitalisations were reported to the medicines authority Swissmedic, as the University of Lucerne announced on Thursday. Yet these reports are very important, study leader Patrick Beeler stressed in a statement.
Most previously unknown risks of medications are discovered in this way. According to the researcher, they thus form the most important cornerstone for drug safety. Beeler advocates that the duty to report be adequately addressed in the training of medical professionals.
In an international comparison, this reporting rate is still high, says Beeler. Internationally, the reporting rate is usually between 0.6 and 4.7%.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
This content was published on
Prices for medical drugs in Switzerland remain significantly higher than in other European countries, even if they have come down slightly.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.